IL1B and atherosclerosis: In summary, ACS patients have higher circulatory EMP levels, which may participate in the regulation of NF‐кB and IL‐1β signal pathways of monocytes/macrophages and influence cell adhesion, proliferation, and macrophage phagocytic capability, contributing to the vascular inflammation associated with atherosclerosis progression in ACS patients.